perillyl alcohol has been researched along with Experimental Mammary Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, KJ; Choi, EK; Griffin, R; Lee, CK; Park, HJ; Song, CW | 1 |
| Gould, MN; Haag, JD | 1 |
2 other study(ies) available for perillyl alcohol and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Cytotoxicity of perillyl alcohol against cancer cells is potentiated by hyperthermia.
Topics: Animals; Antineoplastic Agents; Apoptosis; Combined Modality Therapy; Drug Synergism; Female; Hyperthermia, Induced; In Situ Nick-End Labeling; Mammary Neoplasms, Experimental; Mice; Mice, Inbred A; Monoterpenes; Time Factors | 2003 |
Mammary carcinoma regression induced by perillyl alcohol, a hydroxylated analog of limonene.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Body Weight; Cyclohexenes; Dose-Response Relationship, Drug; Eating; Female; Limonene; Mammary Neoplasms, Experimental; Monoterpenes; Rats; Rats, Wistar; Terpenes; Time Factors | 1994 |